MedTrace Logo

Tear Based Sample Collection Breast Cancer Detection

NCT04974567 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-12-11

No results posted yet for this study

Summary

This study aims to collect tear samples from 50 women who have been recently diagnosed with breast cancer.

Conditions

Interventions

OTHER

Schirmer Strip

A tear-based screening assay for breast cancer developed and validated by Namida Lab, Inc., a high complexity CLIA certified lab. It consists of two parts: tear sample collection using a Schirmer Strip and a clinical lab-developed test that measures protein biomarkers for breast cancer screening.

Sponsors & Collaborators

  • The University of Texas Medical Branch, Galveston

    collaborator OTHER

  • Namida Lab

    lead INDUSTRY

Principal Investigators

  • Suzanne Klimberg, MD, PhD · UTMB Health

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-28
Primary Completion
2024-08-31
Completion
2025-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04974567 on ClinicalTrials.gov